There will be a steady increase in the number of initial public offerings in the US through 2025, albeit no “switch will be ...

On Monday, Carlyle Group Inc (CG) stock saw a modest uptick, ending the day at $50.86 which represents a slight increase of $0.40 or 0.79% from the prior close of $50.46. The stock opened at $50.06 ...

QuidelOrtho Corporation (Nasdaq: QDEL) (the "Company" or "QuidelOrtho"), a global provider of innovative in vitro diagnostics technologies designed for point-of-care settings, clinical labs and ...

Private Advisor Group LLC lessened its stake in The Carlyle Group Inc. (NASDAQ:CG – Free Report) by 12.7% in the 3rd quarter, ...

In 2015, the four founders of Churchill Financial split with their private equity owner, Carlyle Group, and relaunched their business with investment advisor TIAA. Today, the firm known as Churchill ...

The Carlyle Group Inc. (NASDAQ:CG) Q3 2024 Earnings Call Transcript November 7, 2024 Operator: Thank you for standing by and ...

Jefferies analyst Daniel Fannon maintained a Hold rating on Carlyle Group (CG – Research Report) today and set a price target of $52.00. The ...

The Carlyle Group Inc. (NASDAQ:CG) reported the third quarter adjusted EPS of $0.95, beating the consensus of $0.90, and ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

QuidelOrtho Corporation (Nasdaq: QDEL) (the "Company" or "QuidelOrtho"), a global provider of innovative in vitro diagnostics technologies designed for point-of-care settings, clinical labs and ...

QuidelOrtho Corp. (QDEL) announced the pricing of the underwritten secondary offering by Carlyle Partners VI Cayman Holdings, L.P.